Akorn Stock Forecast, Price & News

+0.00 (+0.75 %)
(As of 10/2/2020)
Today's Range
50-Day Range
52-Week Range
Volume1.19 million shs
Average Volume7.44 million shs
Market Capitalization$3.60 million
P/E RatioN/A
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive AKRXQ News and Ratings via Email

Sign-up to receive the latest news and ratings for Akorn and its competitors with MarketBeat's FREE daily newsletter.

About Akorn

Akorn, Inc., a specialty pharmaceutical company, develops, manufactures, and markets generic and branded prescription pharmaceuticals, over-the-counter (OTC) consumer health products, and animal health pharmaceuticals in the United States and internationally. The company operates in two segments, Prescription Pharmaceuticals and Consumer Health. The Prescription Pharmaceuticals segment offers generic and branded prescription pharmaceuticals in various dosage forms, including sterile ophthalmics, injectables, and inhalants; and non-sterile oral liquids, topicals, nasal sprays, and otics. Its primary products include Akten, a topical ocular anesthetic gel; AzaSite, an antibiotic used to treat bacterial conjunctivitis; Cosopt, Cosopt PF, Betimol, and Zioptan, which are used in the treatment of glaucoma; and Xopenex inhalation solution used in the treatment or prevention of bronchospasm. The Consumer Health segment manufactures and markets OTC products for the treatment of dry eye under the TheraTears brand. It also markets other OTC consumer health products comprising Mag-Ox, a magnesium supplement; and the Diabetic Tussin line of cough and cold products. In addition, this segment offers a portfolio of animal health products, such as Anased and VetaKet veterinary sedatives; Tolazine and Yobine sedative reversing agents; and Butorphic, a pain reliever. Further, the company sells its products to wholesale distributors. Akorn, Inc. was founded in 1971 and is headquartered in Lake Forest, Illinois. On May 20, 2020, Akorn, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.


AKRXQ Jan 2021 5.500 call
AKRXQ Jan 2021 5.500 call
August 22, 2020 |  ca.finance.yahoo.com
Akorn EPS misses by $0.12, misses on revenue
Akorn EPS misses by $0.12, misses on revenue
August 7, 2020 |  seekingalpha.com
Akorn Provides Second Quarter 2020 Results
Akorn Provides Second Quarter 2020 Results
August 7, 2020 |  finance.yahoo.com
Akorn, Inc. (AKRXQ)
Akorn, Inc. (AKRXQ)
August 1, 2020 |  finance.yahoo.com
AKRXQ Jan 2021 0.500 put
AKRXQ Jan 2021 0.500 put
August 1, 2020 |  finance.yahoo.com
Akorn Inc.
Akorn Inc.
July 17, 2020 |  www.barrons.com
See More Headlines

Industry, Sector and Symbol

Sales & Book Value






Overall MarketRank

0.13 out of 5 stars

Medical Sector

1899th out of 2,099 stocks

Pharmaceutical Preparations Industry

777th out of 831 stocks

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

Akorn (OTCMKTS:AKRXQ) Frequently Asked Questions

What stocks does MarketBeat like better than Akorn?

Wall Street analysts have given Akorn a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Akorn wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Who are some of Akorn's key competitors?

What is Akorn's stock symbol?

Akorn trades on the OTCMKTS under the ticker symbol "AKRXQ."

How do I buy shares of Akorn?

Shares of AKRXQ can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Akorn's stock price today?

One share of AKRXQ stock can currently be purchased for approximately $0.03.

How much money does Akorn make?

Akorn has a market capitalization of $3.60 million and generates $682.43 million in revenue each year.

How many employees does Akorn have?

Akorn employs 2,227 workers across the globe.

What is Akorn's official website?

The official website for Akorn is www.akorn.com.

Where are Akorn's headquarters?

Akorn is headquartered at 1925 WEST FIELD COURT SUITE 300, LAKE FOREST IL, 60045.

How can I contact Akorn?

Akorn's mailing address is 1925 WEST FIELD COURT SUITE 300, LAKE FOREST IL, 60045. The company can be reached via phone at 847-279-6100 or via email at [email protected]

This page was last updated on 6/14/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.